http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-202009007976-U1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27db82df7ae375f1490794238b72b16a |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-79 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-81 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4412 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-79 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-81 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-68 |
| filingDate | 2009-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2009-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | DE-202009007976-U1 |
| titleOfInvention | Novel pharmaceuticals and drug formulations which inhibit tumor cell proliferation and / or tumor vascularization and their action as multi-kinase inhibitors |
| abstract | Compound of the general formula I or in the R 1 represents a fluorine or a chlorine atom or a trifluoromethyl group, R 2 represents a hydrogen atom or a C 1 -C 4 -alkyl group which may be unbranched or branched, R 3 is a hydrogen atom, a C 1 -C 4 alkyl group which may be unbranched or branched or a hydroxy group, stands, and their salts with physiologically acceptable counterions, their prodrugs, their pyridine N-oxides and their other metabolites , |
| priorityDate | 2009-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 131.